Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
5 mg Dose: Draw 50 units (0.5 mL)
These two changes are helpful for many people, but they may be difficult to maintain
A Phase 2 trial (NCT01311518) was designed to test RGN-352 in ~75 heart attack patients, but was placed on FDA clinical hold in 2011 due to manufacturing (GMP) compliance issues at the contract site not safety concerns with the drug itself
the social media presence is the community confirmation
Take the quiz Complete a 2 minute health assessment to get pre-approved for treatment instantly
US$ 22.83
US$ 28.73
US$ 21.02
US$ 29.11
